24 Oct 2008 10:41
Taihua plc
("Taihua" or the "Company")
Application Update
Taihua announces that the European Directorate for Quality of Medicines ("EDQM") has now responded to its application for a certificate of suitability (COS) for paclitaxel.
As anticipated, the regulatory body has requested some supplementary data on certain aspects of the manufacturing process. Taihua is now in the process of collating this additional information and further updates will be provided in due course.
For more information please contact:
|
David Youngman/Katy Mitchell WH Ireland Limited |
Tel: +44 (0) 161 832 2174 |
|
Mike Wyllie, Chief Scientific Officer, Taihua plc |
+44 1795 597330 |
Follow the stocks